Join
Live feed
·
INSIDERFilingvia Quantisnow
Enveric Biosciences Inc. logo

CHIEF FINANCIAL OFFICER Coveney Kevin Michael was granted 100,000 shares, increasing direct ownership by 116% to 186,500 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ENVB· Enveric Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENVB (Enveric Biosciences Inc.) and more on Quantisnow.